Federal Cannabis Standards Could Tighten: ProGuard’s Role In Ensuring Pharma-Grade Cannabis Cultivation
As the cannabis industry moves towards potential federal regulation and rescheduling for pharmaceutical-grade production, strict adherence to biosecurity measures and microbial lab test regulations becomes critical.
Rescheduling marijuana could intensify FDA oversight, necessitating comprehensive control of the entire cannabis supply chain. Under pharmaceutical standards, rigorous testing encompasses everything from water supply to air quality, highlighting the pivotal role of air control in maintaining pollutant-free cultivation sites.
Mike D’Ambra, co-founder of Innovative Solutions, leads the charge with ProGuard Air & Surface sanitization technology, an active indoor sanitation solution specializing in pathogen control in cannabis cultivation, that is paving the way for pharmaceutical-grade standards.
A Pivot To Cannabis
Originally catering to sectors such as Food Safety and Biotech, a call in 2013 led D’Ambra’s team to pivot towards the cannabis industry. Faced with the challenge of maintaining medical-grade air quality in a high-humidity cultivation environment, they adapted their ProGuard technology to meet the unique demands of cannabis cultivation.
This marked a turning point, as the technology’s success in this new application opened up a burgeoning market ripe for innovation.
Want to know more about companies and investment opportunities in the cannabis industry? Join us at the upcoming Benzinga Cannabis Capital Conference in Florida at the new Hollywood venue on April 16 and 17, 2024.
Meeting Pharma-Grade Expectations
ProGuard’s unique approach to sanitization, combining Bi-Polar Ionization (BPI) and photocatalytic oxidation, offers an advanced solution capable of meeting and surpassing the rigorous standards set for pharmaceutical products.
This technology’s ability to thrive in …